Related Experiment Video
Updated: May 11, 2026
13:04
A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
Ever closer to a prophylactic vaccine for HCV
Leo Swadling1, Paul Klenerman, Eleanor Barnes
1University of Oxford, NDM and Jenner Institute, Peter Medawar Building, South Parks Road, Oxford, OX1 3SY, UK.
Expert Opinion on Biological Therapy
|May 9, 2013
Summary
Developing a hepatitis C virus (HCV) vaccine is crucial for global health, as current vaccine technologies can induce protective immune responses. Further research and clinical trials are needed to establish correlates of protection and achieve a viable HCV vaccine.
Area of Science:
- Virology
- Immunology
- Vaccinology
Background:
- Hepatitis C virus (HCV) infection is a significant global health issue, with millions of new cases annually.
- Despite treatment advancements, an effective vaccine remains the most viable strategy to reduce HCV's global burden.
Purpose of the Study:
- To review immune responses during natural HCV infection to guide vaccine development.
- To assess current candidate HCV vaccines against requirements for an effective prophylactic vaccine.
Main Methods:
- Discussion of immune responses to HCV during natural infection.
- Introduction and comparison of current candidate HCV vaccines.
- Evaluation of vaccine-induced immune responses (breadth, functionality, magnitude, phenotype).
Main Results:
- Vaccine technologies can now elicit HCV-specific adaptive immune responses comparable to those seen in natural protection.
- Correlates of immune protection against HCV are not fully defined.
Conclusions:
- Establishing well-characterized cohorts for vaccine efficacy testing is essential.
- Further understanding of correlates of protection from natural history studies is needed.
- An effective HCV vaccine is an achievable goal with continued research and development.
Related Concept Videos
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:28Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:27Cytomegalovirus Disease
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...